OTC Ads’ Vioxx Comparisons Communicate “Options,” Pitts Says
This article was originally published in The Tan Sheet
Executive Summary
OTC analgesic ads comparing the pain relievers to Vioxx (rofecoxib) do not cross the boundary of propriety, according to Peter Pitts, senior VP-health affairs at the public relations firm Manning, Selvage & Lee (New York)